Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): Long-term (5-year) controlled observational data in placebo-treated patients

European Journal of Dermatology

Volumn 18, Issue 4, 2008, Pages 407-411

  Kaufman, Keith D ^a   Girman, Cynthia J ^a   Round, Elizabeth M ^a   Johnson Levonas, Amy O ^a   Shah, Arvind K ^a   Rotonda, Jennifer ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

5 reductase inhibitor; Androgenetic alopecia; Finasteride; Global photographic assessment; Patient self assessment

Indexed keywords

FINASTERIDE; PLACEBO;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; HAIR GROWTH; HAIR LOSS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PHOTOGRAPHY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCALP HAIR; SELF EVALUATION;

ADOLESCENT; ADULT; ALOPECIA; DERMATOLOGIC AGENTS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FINASTERIDE; HAIR; HUMANS; MALE; PLACEBOS;

EID: 47749108246     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0435     Document Type: Article

References (16)

1. Hamilton JB. Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat 1942; 71: 451-80.
2. Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acad Sci 1951; 53: 708-28.
3. Price VH. Testosterone metabolism in the skin. Arch Dermatol 1975; 111: 1496-502.
4. Whiting DA. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad Dermatol 1993; 28: 755-63.
5. Olsen EA. Androgenetic alopecia. In: Olsen EA, ed. Disorders of hair growth: diagnosis and treatment. New York: McGraw-Hill, Inc., 1994: 257-83.
6. Lopez-Bran E, Robledo A, Aspiolea F, Moragas JM, Yu A, Quintanilla E, Sambrico F, del Pino J. Multicenter comparative study of the efficacy of topical 2% minoxidil (Rogaine) versus placebo in the treatment of male baldness. Adv Ther 1990; 7: 159-68.
7. Olsen EA, Buller TA, Weiner S, Delong ER. Natural history of androgenetic alopecia. Clin Exp Derm 1990; 15: 34-6.
8. Rushton DH, Ramsay ID, Norris MJ, Gilkes JJH. Natural progression of male pattern baldness in young men. Clin Exp Derm 1991; 16: 188-92.
9. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van-Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol 1998; 39: 578-88.
10. Finasteride Male Pattern Hair Loss Study Group. Long term (5 year) multinational experience with finasteride 1 mg in the treatment of androgenetic alopecia. Eur J Dermatol 2002; 12: 38-49.
11. Norwood O. Male pattern baldness: classification and incidence. South Med J 1975; 68(11): 1359-65.
12. Takashima I, Iju M, Sudo M. Alopecia androgenetica - its incidence in Japanese and associated conditions. In: Orfanos CE, Montagna W, Stüttgen G, eds. Hair research. Status and future aspects. New York: Springer-Verlag, 1981: 287-93.
13. Barber BL, Kaufman KD, Kozloff RC, Girman CJ, Guess HA. Hair growth questionnaire for use in the evaluation of therapeutic effects in men. J Dermatol Treat 1998; 9: 181-6.
14. Aktan S, Akarsu S, Ilknur T, Demirtasoglu M, Ozkan S. Quantification of female pattern hair loss: a study in a Turkish population. Eur J Dermatol 2007; 17: 321-4.
15. Rhodes T, Girman CJ, Savin RC, Kaufman KD, Guo S, Lilly FR, Siervogel RM, Chumlea WC. Prevalence of male pattern hair loss in 18-49 year old men. Dermatol Surg 1998; 24: 1330-2.
16. Kaufman KD, Rotonda J, Shah AK, Meehan AG. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss). Eur J Dermatol 2008; 18(4): 400-6.